We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New Rapid Test Accurately Identifies Eosinophils in Sputum to Guide Asthma Treatment

By LabMedica International staff writers
Posted on 03 Aug 2023

Following years of extensive research into the fundamental causes of asthma and other respiratory diseases, a group of scientists has developed a simple, rapid diagnostic test capable of identifying a key driver of severe asthma. More...

Researchers at McMaster University (Hamilton, ON, Canada) and St. Joseph’s Healthcare Hamilton (Ontario, Canada) have spearheaded the development of a novel rapid test that quickly and accurately detects eosinophils, a type of white blood cell, by identifying their protein signatures, even in complex biological specimens such as sputum. Quick access to this reliable information about eosinophils can aid doctors in making critical patient care decisions. The test resembles the familiar COVID-19 home test, enabling easy adaptation for its large-scale production once approved for clinical application.

The researchers created this test by developing a protein-targeting component called a DNAzyme and modifying it for use in the rapid test. DNAzymes, first isolated in 1994, have primarily been used for detecting metals or bacterial targets. No one had previously succeeded in leveraging DNAzymes to target specific protein markers. Having surmounted this challenge, the researchers now believe that this test platform could be tailored to identify any biologically-derived material through its protein signature.

The team is now planning a comprehensive clinical trial for this novel test, marking the next crucial step towards its market launch. A rapid diagnostic test for detecting elevated eosinophil levels could assist clinicians in making informed decisions about the administration of medications such as steroids or new biologics to patients suffering from severe asthma and other lung conditions linked to eosinophilia, including severe cough and chronic obstructive pulmonary disease (COPD). Additionally, the test could help curb the unnecessary usage of antibiotics.

“This test and others like it can have the kind of lasting, meaningful impact that will improve or even save many lives,” said John Brennan, director of McMaster’s Biointerfaces Institute.

Related Links:
McMaster University 
St. Joseph’s Healthcare Hamilton


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.